MAPT and Alzheimer disease: In APOE4 carriers, the presence versus the absence of BCHE-K alleles associated with a significantly earlier mean age-at-diagnosis of AD of 6.4 years, a more limbic-amnestic phenotype, and similar accumulations of amyloid and tau pathology but more than 6 years earlier.